BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2022 7:50:06 AM | Browse: 267 | Download: 714
 |
Received |
|
2022-01-19 20:50 |
|
Peer-Review Started |
|
2022-01-19 20:51 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-29 07:39 |
|
Revised |
|
2022-06-28 02:46 |
|
Second Decision |
|
2022-07-27 02:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-07-27 17:48 |
|
Articles in Press |
|
2022-07-27 17:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-07-23 04:05 |
|
Typeset the Manuscript |
|
2022-08-03 05:53 |
|
Publish the Manuscript Online |
|
2022-08-26 07:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Impact of microbiota-immunity axis in pancreatic cancer management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ilenia Bartolini, Giulia Nannini, Matteo Risaliti, Francesco Matarazzo, Luca Moraldi, Maria Novella Ringressi, Antonio Taddei and Amedeo Amedei |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amedeo Amedei, PhD, Professor, Department of Experimental and Clinical Medicine, SOD of Interdisciplinary Internal Medicine, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence 50134, Italy. amedeo.amedei@unifi.it |
| Key Words |
Gastrointestinal tumors; Hepatopancreatobiliary tumors; Pancreatic cancer; Gut microbiota; Dysbiosis; Cancer development; Carcinogenesis |
| Core Tip |
Despite improvements in traditional patient treatment, pancreatic cancer remains a tumor with an increasing incidence and a poor prognosis, often diagnosed in late stages. The oral, gut, biliary, and intrapancreatic microbiota might contribute to pancreatic cancer through different pathways including a complex interplay with the immune system. Comprehending these complicated relationships could help researchers better understand the pathogenesis of pancreatic cancer, thus providing new promising options for early diagnosis, therapeutic targets, and risk stratification hoping that could translate into better and longer patient survival. |
| Publish Date |
2022-08-26 07:50 |
| Citation |
Bartolini I, Nannini G, Risaliti M, Matarazzo F, Moraldi L, Ringressi MN, Taddei A, Amedei A. Impact of microbiota-immunity axis in pancreatic cancer management. World J Gastroenterol 2022; 28(32): 4527-4539 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i32/4527.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i32.4527 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
